HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health, Beauty And Wellness News: SIDI Protocol, Synthetic Labeling Survey, Recalls, Product Launches

This article was originally published in The Rose Sheet

Executive Summary

Prebiotic aloe in a Veralixir shot; Carpe targets excessive sweating; Young Living offers subscriptions; Berry Sleepy puts $2.8m behind marketing; Jigsaw supports children's Mineral Power program; Trust Transparency survey on synthetic ingredient labeling; and Beaumont Bio homeopathics recalled.

You may also be interested in...



Health, Beauty And Wellness Regulatory News: Warnings, Alerts, Recalls

Fourth recall of homeopathics linked to contaminated water; FDA posts alerts about Texas coop's products; and warnings note drug claims, GMP problems, same-site drug production.

Health, Beauty And Wellness News: HelloLife Recall, Nutraceutical Advisor And Foot Ease, Nutra Collagen Launches

HelloLife recalls products made at King Bio facility; Nutraceutical advisor is microbiome medicine pioneer; Foot Ease targets plantar fasciitis with nutrition; and Nutra Collagen available from Advanced Protein.


SIDI Supplier Protocol Update Adds To Burgeoning Self-Regulation Library

SIDI's draft protocol update incorporates changes to guide compliance with rules established by FSMA relevant to supplement firms and adds information on economically motivated adulteration and determining whether dietary ingredients are grandfathered as compliant under DSHEA.

Topics

UsernamePublicRestriction

Register

RS121819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel